Literature DB >> 7596195

Antinuclear antibodies in healthy aging people: a prospective study.

R M Xavier1, Y Yamauchi, M Nakamura, Y Tanigawa, H Ishikura, T Tsunematsu, S Kobayashi.   

Abstract

In order to evaluate the expression of antinuclear antibodies (ANA) in normal elderly individuals over time and clinical significance, a cross-sectional ANA testing in healthy Japanese was performed, followed by annual evaluations of ANA positive aged (> or = 65 years) and a control group. ANA was more prevalent in the aged (11.4% vs. 3.8%) and most were persistent after 4 years. Anti-ssDNA and anti-histone antibodies were increased in aged ANA positive as compared to ANA negative controls. Except for a history of spontaneous abortion, there was no differences in clinical findings. HLA DRB1*0901 and the DQB1*0602 + 0302 + 0303 set of alleles were increased in ANA positive. Therefore, ANA in the aged were persistent, apparently directed toward chromatin elements, and shared MHC associations with autoimmune diseases. Longer follow-up may be necessary to improve the evaluation of clinical significance of ANA in the aged.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7596195     DOI: 10.1016/0047-6374(94)01532-q

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  17 in total

1.  Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis.

Authors:  Jihua Yang; Shunchang Jiao; Jingbo Kang; Rong Li; Guanzhong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 2.  Immunologic states of autoimmune diseases.

Authors:  Toru Abo; Toshihiko Kawamura; Hisami Watanabe
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Uveitis in the elderly--is it easy to identify the masquerade?

Authors:  P Zamiri; S Boyd; S Lightman
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

4.  The prevalence of autoantibodies in an elderly sub-Saharan African population.

Authors:  R Njemini; I Meyers; C Demanet; J Smitz; M Sosso; T Mets
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

5.  Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay.

Authors:  R A Gniewek; D P Stites; T M McHugh; J F Hilton; M Nakagawa
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

6.  Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.

Authors:  Minoru Satoh; Edward K L Chan; Lindsey A Ho; Kathryn M Rose; Christine G Parks; Richard D Cohn; Todd A Jusko; Nigel J Walker; Dori R Germolec; Irene Z Whitt; Patrick W Crockett; Brad A Pauley; Jason Y F Chan; Steven J Ross; Linda S Birnbaum; Darryl C Zeldin; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2012-07

7.  Screening for associated autoimmune disorders in Polish patients with Addison's disease.

Authors:  Marta Fichna; Piotr Fichna; Maria Gryczyńska; Jarosław Walkowiak; Magdalena Zurawek; Jerzy Sowiński
Journal:  Endocrine       Date:  2010-03-16       Impact factor: 3.633

8.  Cellular aging over 13 years associated with incident antinuclear antibody positivity in the Baltimore Longitudinal Study of Aging.

Authors:  Helen C S Meier; Christine G Parks; Hans B Liu; Dale P Sandler; Eleanor M Simonsick; Kevin Deane; Nan-Ping Weng
Journal:  J Autoimmun       Date:  2019-07-11       Impact factor: 7.094

9.  The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.

Authors:  D Alpizar-Rodriguez; Laure Brulhart; Ruediger B Mueller; Burkhard Möller; Jean Dudler; Adrian Ciurea; Ulrich A Walker; Ines Von Mühlenen; Diego Kyburz; Pascal Zufferey; Michael Mahler; Sylvette Bas; Danielle Gascon; Céline Lamacchia; Pascale Roux-Lombard; Kim Lauper; Michael J Nissen; Delphine S Courvoisier; Cem Gabay; Axel Finckh
Journal:  Clin Rheumatol       Date:  2017-01-21       Impact factor: 2.980

10.  Sex differences in the association between antinuclear antibody positivity with diabetes and multimorbidity in older adults: Results from the Baltimore Longitudinal Study of Aging.

Authors:  Helen C S Meier; Dale P Sandler; Eleanor M Simonsick; Nan-Ping Weng; Christine G Parks
Journal:  Exp Gerontol       Date:  2020-03-05       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.